These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 31715276)
1. Liposomal mupirocin holds promise for systemic treatment of invasive Staphylococcus aureus infections. Goldmann O; Cern A; Müsken M; Rohde M; Weiss W; Barenholz Y; Medina E J Control Release; 2019 Dec; 316():292-301. PubMed ID: 31715276 [TBL] [Abstract][Full Text] [Related]
2. New Synergistic Combination Therapy of Mupirocin and α-Pinene Against Multidrug-Resistant Clinical Strains of Methicillin-Resistant Staphylococcus aureus. Cáceres-Guido P; Martín-Vázquez N; Ojeda-Sana A; Van Baren C; Balbarrey Z; Moreno S P R Health Sci J; 2024 Jun; 43(2):73-78. PubMed ID: 38860960 [TBL] [Abstract][Full Text] [Related]
3. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Semret M; Miller MA Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789 [TBL] [Abstract][Full Text] [Related]
4. How resistant is Staphylococcus aureus to the topical antibiotic mupirocin? Rakshit T; Shenoy M S J Glob Antimicrob Resist; 2017 Mar; 8():102-103. PubMed ID: 28082145 [No Abstract] [Full Text] [Related]
5. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin. Dorrani M; Kaul M; Parhi A; LaVoie EJ; Pilch DS; Michniak-Kohn B Int J Pharm; 2014 Dec; 476(1-2):199-204. PubMed ID: 25263100 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model. Mohammad H; Cushman M; Seleem MN PLoS One; 2015; 10(11):e0142321. PubMed ID: 26536129 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus. Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923 [TBL] [Abstract][Full Text] [Related]
10. Azithromycin-loaded liposomes for enhanced topical treatment of methicillin-resistant Staphyloccocus aureus (MRSA) infections. Rukavina Z; Šegvić Klarić M; Filipović-Grčić J; Lovrić J; Vanić Ž Int J Pharm; 2018 Dec; 553(1-2):109-119. PubMed ID: 30312749 [TBL] [Abstract][Full Text] [Related]
11. Detection of methicillin-resistant Staphylococcus aureus with high-level resistance to mupirocin. Nakajima J; Hitomi S; Kurihara Y J Infect Chemother; 2011 Dec; 17(6):868-71. PubMed ID: 21484296 [TBL] [Abstract][Full Text] [Related]
12. In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus. Narayanaswamy VP; Giatpaiboon SA; Uhrig J; Orwin P; Wiesmann W; Baker SM; Townsend SM PLoS One; 2018; 13(1):e0191522. PubMed ID: 29342216 [TBL] [Abstract][Full Text] [Related]
13. Preliminary investigations into developing all-D Omiganan for treating Mupirocin-resistant MRSA skin infections. Ng SMS; Teo SW; Yong YE; Ng FM; Lau QY; Jureen R; Hill J; Chia CSB Chem Biol Drug Des; 2017 Dec; 90(6):1155-1160. PubMed ID: 28581672 [TBL] [Abstract][Full Text] [Related]
14. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda. Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276 [TBL] [Abstract][Full Text] [Related]
15. Distribution of high-level mupirocin resistance among clinical MRSA. Mahmoodzadeh Hosseini H; Kiyani N; Amin M; Hedayati Ch M; Imani Fooladi AA J Chemother; 2017 Aug; 29(4):215-219. PubMed ID: 27376552 [TBL] [Abstract][Full Text] [Related]
16. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Orrett FA Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397 [TBL] [Abstract][Full Text] [Related]
17. Mupirocin Resistance Among Methicillin Resistant Staphylococcus Isolates in a Tertiary Health Care Center. Mittal S; Sayal P; Yadav P; Kumar A; Rajian M Infect Disord Drug Targets; 2019; 19(2):128-132. PubMed ID: 29714149 [TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect and postantibiotic sub-MIC effect of LTX-109 and mupirocin on Staphylococcus aureus blood isolates. Saravolatz LD; Pawlak J; Martin H; Saravolatz S; Johnson L; Wold H; Husbyn M; Olsen WM Lett Appl Microbiol; 2017 Nov; 65(5):410-413. PubMed ID: 28802058 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Subinhibitory Concentrations of Kwiatkowski P; Grygorcewicz B; Pruss A; Wojciuk B; Dołęgowska B; Giedrys-Kalemba S; Sienkiewicz M; Wojciechowska-Koszko I Microb Drug Resist; 2019 Dec; 25(10):1424-1429. PubMed ID: 31314694 [No Abstract] [Full Text] [Related]